Fingerprint
Dive into the research topics of 'Synergistic interaction between the HDAC inhibitor, MPT0E028, and sorafenib in liver cancer cells in vitro and in vivo'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Synergistic interaction between the HDAC inhibitor, MPT0E028, and sorafenib in liver cancer cells in vitro and in vivo
Chun Han Chen, Mei Chuan Chen, Jing Chi Wang, An Chi Tsai, Ching Shih Chen, Jing Ping Liou, Shiow Lin Pan, Che Ming Teng
- Ph.D. Program in Drug Discovery and Development Industry
- Department of Pharmaceutical Sciences
- Ph.D. Program for Cancer Molecular Biology and Drug Discovery
- TMU Research Center of Drug Discovery
- TMU Research Center of Thoracic Medicine
- TMU Research Center of Cancer Translational Medicine
- Master Program in Clinical Genomics and Proteomics
- Ph. D. Program in the Clinical Drug Development of Herbal Medicine
- Graduate Institute of Pharmacognosy
Research output: Contribution to journal › Article › peer-review
46
Citations
(Scopus)